CEACAM5 and neoplasm: As far as blood biomarkers, perioperative peripheral venous circulating tumor cells (CTCs), circulating tumor DNA (ctDNA) and CEA, and pulmonary venous CTCs predicted unfavorable outcomes and distant metastases [299].